Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized esketamine and dexmedetomidine for prevention of postoperative sore throat in colorectal cancer surgery
ChiCTR2300072375Phase 4Not yet recruiting
- Sponsor
- Anesthesiology Research Institute
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of esketamine and dexmedetomidine in Post-extubation sore throat (POST) (4 arms), sponsored by Anesthesiology Research Institute. Primary endpoint: Incidence of postoperative sore throat. Planned start Jul 2023; status: not yet recruiting.
02
Drugs
esketaminedexmedetomidine
03
Conditions
Post-extubation sore throat (POST)
Beyond the preview
Go deeper on ChiCTR2300072375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300072375.